From: Is routine karyotyping required in prenatal samples with a molecular or metabolic referral?
Disease | N | Normal karyotype | ≥ 36 years | Abnormal karyotype | Abnormal karyotype (≥ 36 years) | Case no. |
---|---|---|---|---|---|---|
 |  |  |  | (< 36 years) |  |  |
Fragile X syndrome | 57 | 57 | 9 | Â | Â | Â |
Huntington's disease | 39 | 37 | 6 | 2 | Â | 1,9 |
Duchenne muscular dystrophy | 33 | 32 | 6 | Â | 1 | 2 |
Spinal Muscular Atrophy | 30 | 27 | 14 | Â | 3 | 5,6,13 |
Myotonic dystrophy | 29 | 26 | 5 | 2 | 1 | 3,11,1 |
Hurler syndrome | 8 | 7 | 2 | 1 | Â | 4 |
Spondyloepiphyseal dysplasia | 7 | 6 | 1 | 1 | Â | 12 |
Hemophagocytic lymphohistiocytosis | 5 | 4 | 1 | 1 | Â | 18 |
Monoamine oxidase A deficiency | 5 | 4 | 2 | 1 | Â | 10 |
X-linked MR | 5 | 4 | Â | 1 | Â | 17 |
Paternity testing | 3 | 2 | 2 | Â | 1 | 19 |
Wilms tumors | 3 | 2 | 1 | Â | 1 | 15 |
Canavan disease | 2 | 1 | 2 | Â | 1 | 7 |
Nonsyndromic hearing loss | 2 | 1 | Â | 1 | Â | 16 |
Nail-patella syndrome | 1 | 0 | Â | 1 | Â | 8 |
Other diseases | 271 | 271 | 56 | Â | Â | Â |
Total | 500 | 481 | 117 | 11 | 8 | Â |